A life sciences company provides products and services that accelerate and improve the discovery and commercialization of human therapeutics.


Updates from The Motley Fool

Latest updates on Cambrex from Fool.com.


Stock Performance

View Interactive CBM Charts
Sponsored by

Key Data Points

Primary metrics and data points about Cambrex.
Current Price: $59.35
Prev Close: $58.60
Open: $58.80
Bid: $59.35
Ask: $0.00
Day's Range: $58.30 - $59.65
52wk Range: $38.30 - $62.50
Volume: 257,393
Avg Vol 307,847
Market Cap: $2B
P/E (ttm): 22.11
EPS (ttm): $2.65
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Cambrex.
CAPS Rating 3 out of 5
 
118 Outperform
18 Underperform
CAPS All Stars
 
28 Outperform
6 Underperform

How do you think Cambrex will perform against the market?



You pick for Cambrex is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Steve Klosk, CEO

50% Approve

Based on 6 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Cambrex.

A life sciences company provides products and services that accelerate and improve the discovery and commercialization of human therapeutics.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers